In this webinar, Dr. Max Salfinger from the National Jewish Health in Denver, Colorado will provide an overview of the TB epidemic in the United States and abroad as well as the various molecular laboratory assays used to diagnose TB. Each laboratory plays an integral role in an overarching system comprised of health care providers, the laboratory community (hospital, commercial, public health and reference laboratories) and TB control.
Key Highlights:
MD, Director, Mycobacteriology & Pharmacokinetics Laboratories, National Jewish Health
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
Max Salfinger, M.D. is currently the Director of the Mycobacteriology and Pharmacokinetics Laboratories at National Jewish Health in Denver, Colorado, and is a Fellow of the Infectious Disease Society of America (FIDSA) and the American Academy of Microbiology (FAAM). Before joining National Jewish Health, he was the Florida State Public Health Laboratory Director from 2006-2012, as well as the Acting Florida State TB Controller for his last 19 months with the Florida Department of Health. Prior to his Florida position, Dr. Salfinger was with the New York State Department of Health Wadsworth Center from 1992 to 2006.
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some text in the Modal Body
Some other text...